New hope for PCOS? Two-Drug combo tested to boost fertility
NCT ID NCT07255911
Summary
This study is testing if adding the drug cabergoline to the standard fertility drug letrozole helps women with Polycystic Ovary Syndrome (PCOS) ovulate more effectively. Researchers will compare the two-drug combination against letrozole alone in 72 women trying to conceive. Participants will be monitored over three menstrual cycles to see which treatment leads to better ovulation rates and fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PCOS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bangladesh Medical University
RECRUITINGDhaka, Shahbag, 1000, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.